Astera Labs, Inc.
ALAB
$320.17
-$1.44-0.45%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 392.40M | 308.36M | 270.58M | 230.58M | 191.93M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 392.40M | 308.36M | 270.58M | 230.58M | 191.93M |
| Cost of Revenue | 104.83M | 73.22M | 66.11M | 54.76M | 46.36M |
| Gross Profit | 287.57M | 235.14M | 204.48M | 175.81M | 145.56M |
| SG&A Expenses | 62.42M | 47.67M | 43.73M | 41.48M | 39.07M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 303.15M | 246.53M | 203.63M | 175.17M | 152.15M |
| Operating Income | 89.25M | 61.83M | 66.96M | 55.41M | 39.77M |
| Income Before Tax | 102.83M | 73.41M | 78.92M | 66.86M | 50.66M |
| Income Tax Expenses | -50.26M | -6.90M | 33.93M | -24.25M | -560.00K |
| Earnings from Continuing Operations | 153.09M | 80.31M | 44.98M | 91.11M | 51.22M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 153.09M | 80.31M | 44.98M | 91.11M | 51.22M |
| EBIT | 89.25M | 61.83M | 66.96M | 55.41M | 39.77M |
| EBITDA | 93.18M | 65.54M | 69.80M | 56.87M | 41.17M |
| EPS Basic | 0.89 | 0.47 | 0.27 | 0.54 | 0.31 |
| Normalized Basic EPS | 0.37 | 0.27 | 0.29 | 0.25 | 0.19 |
| EPS Diluted | 0.83 | 0.44 | 0.25 | 0.50 | 0.29 |
| Normalized Diluted EPS | 0.35 | 0.25 | 0.27 | 0.23 | 0.18 |
| Average Basic Shares Outstanding | 172.38M | 170.73M | 169.51M | 167.44M | 165.43M |
| Average Diluted Shares Outstanding | 183.34M | 181.16M | 181.18M | 180.63M | 178.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |